Serum 25-hydroxyvitamin D levels correlated with risk for dyslipidemia.
ACC 2016 Complete Coverage
Echocardiography and early intervention may be cost-effective in older patients with type 2 diabetes.
Children who exhibited at least 4 unhealthy behaviors were more likely to be obese and have unfavorable cholesterol levels.
After 5 years, more patients in the surgery group had lower blood glucose than in medication-only group.
Many people estimated their risk to be as high as 80%.
Evacetrapib did lower low-density lipoprotein cholesterol in high vascular risk patients, but did not reduce major cardiovascular events.
Certain SNPs may indicate which type 2 diabetes patients with coronary artery disease will experience a cardiovascular event.
Having both diseases raises a patient's chances for developing diabetes.
The association between hand grip strength and cardiovascular events was independent of traditional risk factors.
Results from HOPE-3 suggest statins can be more widely used in intermediate-risk patients without cardiovascular disease.
Certain biomarkers as well as baseline factors were specifically related to sudden cardiac death.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Effect of Sugar-Sweetened Beverages on Obesity Development
- Metformin and PCOS: Improving Menstrual Cycle and Hormone Profiles
- Denosumab May Increase BMD in Women With Primary Hyperparathyroidism
- T2D May Play a Protective Role Against Developing Aortic Diseases
- Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis
- Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease
- SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D
- Type 2 Diabetes Insulin Initiation: Predictors Identified
- Two New Diabetes Medications Now Available
- Managing Acute Pain in Patients With Severe Obesity
- Risk for Congenital Malformations With Antithyroid Drugs
- Occupational Therapy May Benefit Young Adults With Diabetes
- Weight Loss May Improve Pain in Patients With Obesity
- Prior Authorizations Are Creating a Challenge for Clinicians
- Effect of Biologic DMARDs on Spinal Fracture Risk in Ankylosing Spondylitis